CDC - Correction

Correction

Correction Vol. 8, No. 2

In the article “Epidemiology of Burkholderia cepacia Complex in Patients with Cystic Fibrosis, Canada” by David P. Speert et al., an error was made in calculations for Table 2 on page 184. The corrected table appears below and online at http://www.cdc.gov/ncidod/eid/vol8no2/01-0163.htm. In addition, the corrected percentages appear in two sentences from the results section on page 183, as follows: Most isolates (82.5%) were from genomovar III and included all strains that clustered in individual centers and appeared to be transmitted from patient to patient. Approximately 10% of infected patients were infected with B. multivorans (genomovar II), but there was little evidence among these isolates of genotypic clustering as determined by RAPD and PFGE.

We regret any confusion this error may have caused.

Table 2. Genomovar or species of Burkholderia cepacia complex or phenotypically similar isolates from cystic fibrosis patients in Canada

Species or genomovar	No. of patients infected with species or genomovar^a	% patients

Genomovar I	1	0.2
Burkholderia multivorans (genomovar II)	43	9.6
Genomovar III	369	82.5
Burkholderia stabilis (genomovar IV)	17	3.8
Burkholderia vietnamiensis (genomovar V)	7	1.6
Burkholderia cepacia complex (not genomovar I-VII)	8	1.8
Burkholderia fungorum	1	0.2
Burkholderia gladioli	5	1.1
Ralstonia pickettii	5	1.1
Pandoraea spp.	5	1.1
Total	461^a

^aSome patients were counted twice if two or more different strains were recovered; therefore, the percentage of patients is based on a denominator of 447.

This page last reviewed March 29, 2002

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention